Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis. - Alasadi Y; Garcia JC; Arani N; Page V; Geng Y; Andersen CR; Tchakarov A; Kitchlu A; Mamlouk O; Abudayyeh A (Clinical kidney journal, 2025)